Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Acetyl Hexapeptide 3

Argireline, Acetyl Hexapeptide-8

Quick Stats
Studies 21
Trials 6
Score 2
2017 pubmed 23 citations

The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study.

Raikou. Vassiliki V; Varvaresou. Athanasia A; Panderi. Irene I; Papageorgiou. Effie E

Key Findings

  • Acetyl‑hexapeptide‑3 significantly lowered wrinkle‑related skin parameters (cR2, cR3) after 20‑60 days.
  • Acetyl‑hexapeptide‑3 also reduced transepidermal water loss (TEWL), indicating a stronger skin barrier.
  • Tripeptide‑10‑citrulline showed anti‑wrinkle activity on its own, and some measurements suggested the two peptides could act synergistically.

Practical Outcomes

  • For DIY skin‑care enthusiasts, adding acetyl‑hexapeptide‑3 (often marketed as Argireline) to a topical formulation may help smooth fine lines and improve skin hydration. Tripeptide‑10‑citrulline could provide similar benefits, and using both together might enhance results, but more research is needed to define optimal concentrations and dosing schedules.

Summary

A small study with 24 healthy volunteers showed that a skin cream containing acetyl‑hexapeptide‑3 (a peptide often called Argireline) reduced wrinkle‑related skin measurements and improved the skin’s water barrier. The related peptide tripeptide‑10‑citrulline also showed anti‑wrinkle effects, and the two together might work better, though the exact benefit of the combo wasn’t clear.

Abstract

Bioactive peptides have beneficial effects on the skin. We investigated to evaluate the effect of acetyl hexapeptide-3 and tripeptide-10 citrulline and the possible synergism between these two peptides. Twenty-four healthy volunteers were randomized to receive combination of acetyl hexapeptide-3 with tripeptide-10 citrulline (Group G1), tripeptide-10 citrulline (Group, G2), acetyl hexapeptide-3 (Group G3), or neither peptide (Group G4) for 60 days. Skin properties evaluated included skin microtopography, parameters cR2 and cR3, and transepidermal water loss (TEWL) using a skin visioscan and a tewameter, respectively. After 20 days, the measurements between G1 and G2 groups (cR2 P=.045, cR3 P=.044), G2 and G3 groups (cR2 P=.017, cR3 P=.017), G3 and G4 groups (CR2 P=.022), and G2 and G4 groups (cR3 P=.028) from baseline were significant. After 60 days, measurements between groups G1 and G3 (cR2 P=.016, cR3 P=.025), groups G2 and G3 (cR2 P=.044, cR3= P=.044), and groups G1 and G4 (cR2 P=.025) were significant. After 20 days, changes in TEWL between groups G1 and G3 (P=.03), groups G2 and G3 (P=.045), and groups G3 and G4 (P=.025) were significant. After 40 days, changes between groups G2 and G3 (P=.028) and groups G3 and G4 (P=.01) from baseline were significant. Our results confirm the antiwrinkle activity of acetyl hexapeptide-3. A significant decrease in TEWL with acetyl hexapeptide-3 treatment is observed. We provided clinical evidence for the antiwrinkle efficacy of tripeptide-10 citrulline and possibly TEWL. The underlying mechanism by which these two peptides can act synergistically was not clear in this study.

Study Information

Provider

pubmed

Year

2017

Date

2017-02-02T00:00:00.000Z

DOI

10.1111/jocd.12314

Citations

23

References

18